Roles and mechanisms of alternative splicing in cancer—implications for care

SC Bonnal, I López-Oreja, J Valcárcel - Nature reviews Clinical …, 2020 - nature.com
Removal of introns from messenger RNA precursors (pre-mRNA splicing) is an essential
step for the expression of most eukaryotic genes. Alternative splicing enables the regulated …

The biological and clinical consequences of RNA splicing factor U2AF1 mutation in myeloid malignancies

Y Zhao, W Cai, Y Hua, X Yang, J Zhou - Cancers, 2022 - mdpi.com
Simple Summary U2 small nuclear RNA auxiliary factor 1 (U2AF1) is one of the most
important RNA splicing genes involved in regulating the alternative splicing of pre-mRNA …

Molecular targeted therapy and immunotherapy for myelodysplastic syndrome

P Lee, R Yim, Y Yung, HT Chu, PK Yip… - International Journal of …, 2021 - mdpi.com
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder
characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and …

Next generation sequencing in AML—on the way to becoming a new standard for treatment initiation and/or modulation?

M Leisch, B Jansko, N Zaborsky, R Greil, L Pleyer - Cancers, 2019 - mdpi.com
Acute myeloid leukemia (AML) is a clonal disease caused by genetic abberations occurring
predominantly in the elderly. Next generation sequencing (NGS) analysis has led to a …

Polycomb complexes in normal and malignant hematopoiesis

V Di Carlo, I Mocavini, L Di Croce - Journal of Cell Biology, 2019 - rupress.org
Epigenetic mechanisms are crucial for sustaining cell type–specific transcription programs.
Among the distinct factors, Polycomb group (PcG) proteins are major negative regulators of …

The genetic landscape of myelodysplastic neoplasm progression to acute myeloid leukemia

C Bănescu, F Tripon, C Muntean - International Journal of Molecular …, 2023 - mdpi.com
Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders
that originate from the hematopoietic stem and progenitor cells that lead to the development …

Myeloid NGS analyses of paired samples from bone marrow and peripheral blood yield concordant results: a prospective cohort analysis of the AGMT Study Group

B Jansko-Gadermeir, M Leisch, FJ Gassner… - Cancers, 2023 - mdpi.com
Simple Summary Myelodysplastic neoplasms and acute myeloid leukemias are often
caused by gene mutations. Next generation sequencing (NGS) has become indispensable …

TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings

C Cumbo, G Tota, L Anelli, A Zagaria… - International Journal of …, 2020 - mdpi.com
TP53 dysregulation plays a pivotal role in the molecular pathogenesis of myelodysplastic
syndromes (MDS), identifying a subgroup of patients with peculiar features. In this review we …

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?

MR Cook, JE Karp, C Lai - EJHaem, 2022 - Wiley Online Library
The natural history of patients with myelodysplastic syndrome (MDS) is dependent upon the
presence and magnitude of diverse genetic and molecular aberrations. The International …

Mutations and karyotype predict treatment response in myelodysplastic syndromes

D Idossa, TL Lasho, CM Finke… - American journal of …, 2018 - Wiley Online Library
We examined the influence of mutations and karyotype on conventional treatment response,
specifically hematological improvement in anemia, in primary myelodysplastic syndromes …